AdvanSix Inc. (NYSE:ASIX – Get Free Report)’s stock price reached a new 52-week high during trading on Monday . The stock traded as high as $32.19 and last traded at $32.04, with a volume of 7789 shares trading hands. The stock had previously closed at $31.68.
Analysts Set New Price Targets
Several equities research analysts have weighed in on the company. StockNews.com lowered AdvanSix from a “buy” rating to a “hold” rating in a research report on Tuesday, November 19th. Piper Sandler upped their price target on shares of AdvanSix from $35.00 to $39.00 and gave the stock an “overweight” rating in a research report on Friday, November 8th.
Check Out Our Latest Research Report on ASIX
AdvanSix Stock Performance
AdvanSix Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Tuesday, November 26th. Shareholders of record on Tuesday, November 12th were given a dividend of $0.16 per share. The ex-dividend date of this dividend was Tuesday, November 12th. This represents a $0.64 dividend on an annualized basis and a yield of 2.01%. AdvanSix’s dividend payout ratio (DPR) is presently 45.39%.
Insider Activity
In other news, CEO Erin N. Kane sold 5,000 shares of the stock in a transaction that occurred on Tuesday, October 1st. The shares were sold at an average price of $30.28, for a total value of $151,400.00. Following the completion of the transaction, the chief executive officer now directly owns 522,795 shares in the company, valued at $15,830,232.60. This trade represents a 0.95 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Christopher Gramm sold 1,951 shares of the business’s stock in a transaction that occurred on Monday, November 25th. The stock was sold at an average price of $32.00, for a total value of $62,432.00. Following the sale, the insider now directly owns 43,463 shares in the company, valued at approximately $1,390,816. The trade was a 4.30 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 15,369 shares of company stock valued at $474,058. Company insiders own 5.60% of the company’s stock.
Institutional Inflows and Outflows
Several large investors have recently bought and sold shares of the company. Boston Partners acquired a new stake in AdvanSix in the 1st quarter valued at about $702,000. First Eagle Investment Management LLC lifted its stake in AdvanSix by 33.0% during the second quarter. First Eagle Investment Management LLC now owns 611,077 shares of the company’s stock valued at $14,006,000 after purchasing an additional 151,470 shares during the last quarter. American Century Companies Inc. lifted its stake in AdvanSix by 5.4% during the second quarter. American Century Companies Inc. now owns 593,834 shares of the company’s stock valued at $13,611,000 after purchasing an additional 30,500 shares during the last quarter. Deprince Race & Zollo Inc. boosted its holdings in AdvanSix by 45.2% during the second quarter. Deprince Race & Zollo Inc. now owns 259,824 shares of the company’s stock worth $5,955,000 after buying an additional 80,915 shares in the last quarter. Finally, Point72 DIFC Ltd acquired a new position in AdvanSix in the second quarter worth approximately $34,000. Institutional investors own 86.39% of the company’s stock.
About AdvanSix
AdvanSix Inc engages in the manufacture and sale of polymer resins in the United States and internationally. It offers Nylon 6, a polymer resin, which is a synthetic material used to produce fibers, filaments, engineered plastics, and films. The company also provides caprolactam to manufacture polymer resins; ammonium sulfate fertilizers to distributors, farm cooperatives, and retailers; and acetone that are used in the production of adhesives, paints, coatings, solvents, herbicides, and engineered plastic resins, as well as other intermediate chemicals, including phenol, monoisopropylamine, dipropylamine, monoallylamine, alpha-methylstyrene, cyclohexanone, methyl ethyl ketoxime, acetaldehyde oxime, 2-pentanone oxime, cyclohexanol, sulfuric acid, ammonia, and carbon dioxide.
Read More
- Five stocks we like better than AdvanSix
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Cerence Up 155% in 2 Days: SoundHound AI’s Fierce Competitor
- What is the S&P/TSX Index?
- Why Warren Buffett Is Selling: A Look at His Latest Market Moves
- What is a Stock Market Index and How Do You Use Them?
- Why Amazon Shares May Never Trade Below $200 Again
Receive News & Ratings for AdvanSix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdvanSix and related companies with MarketBeat.com's FREE daily email newsletter.